Moderna: From startup to $25 billion biotech developing coronavirus vaccine – Business Insider

Share this Story

Moderna has broken fundraising records and moved with historic speed to lead the race for a coronavirus vaccine. Can it live up to the hype?

Author: Andrew Dunn

READ MORE